by N-Methyl Diethanolamine (NDEA or MDEA) is an organic compound that can be used for gas treating applications. It is a versatile amine compound that has been used in the oil & gas industry for acid gas removal in processes like natural gas sweetening, hydrogen sulfide scavenging, and carbon dioxide removal. MDEA performs exceptionally well in removing acid gases like carbon dioxide and hydrogen sulfide from high-pressure gas streams in gas treatment units. The captured CO2 can then be utilized for processes like enhanced oil recovery. The growing focus on reducing greenhouse gas emissions and deploying carbon capture & storage technology has increased the demand for MDEA in recent years.
The Global N-Methyl Diethanolamine (MDEA) Market Size is estimated to be valued at US$ 773.71 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period from 2024 to 2030.
Key Takeaways
Key players – Key players operating in the N-Methyl Diethanolamine (MDEA) are GlaxoSmithKline plc, Novartis AG, Pfizer Inc., AstraZeneca plc, Boehringer Ingelheim International GmbH, Roche Holding AG, Teva Pharmaceutical Industries Ltd., Bayer AG, Sanofi S.A., Sunovion Pharmaceuticals Inc., Mylan N.V., Cipla Ltd., Grifols S.A., Insmed Incorporated, Arbor Pharmaceuticals LLC. These companies are investing heavily in improving their production capacities and capabilities.
Growing demand – The growing focus on reducing carbon emissions through initiatives like carbon capture, utilization, and storage has increased the demand for MDEA from industries like oil & gas, power generation, and others. Stringent environmental norms are further driving the consumption of MDEA.
Global expansion – Key players are expanding their global footprint by enhancing their distribution networks overseas and catering to the growing demand from international markets. mergers and acquisitions are allowing companies to tap new regions.
Market key trends
One of the key trends in the N-Methyl Diethanolamine (MDEA) market is the shifting focus towards more sustainable production methods. With environment protection becoming a priority, manufacturers are investing in environment-friendly technologies to reduce the carbon footprint of MDEA production. Adopting renewable energy sources and utilizing carbon recycling are some initiatives being taken up. Continuous research towards developing advanced and efficient acid gas treatment technologies using MDEA is also expected to drive the demand for N-Methyl Diethanolamine.
Porter’s Analysis
Threat of new entrants: New manufacturers could enter the market by establishing production facilities. However, the high costs required for MDEA production poses a barrier.
Bargaining power of buyers: The presence of many buyers gives them higher bargaining power against manufacturers in negotiating prices.
Bargaining power of suppliers: A few key manufacturers control the supply of raw materials for MDEA production globally. This gives them higher bargaining power over buyers.
Threat of new substitutes: There exist substitute chemicals that can be used for similar applications. Continuous R&D widens choices for end-use industries.
Competitive rivalry: Global MDEA market is consolidated with major players differentiating through product quality and supplying capability.
Around half of the global MDEA market value is concentrated in Asia Pacific region driven by large scale end-use industries like gas sweetening established here.
North America region is witnessing the fastest value growth in the MDEA market currently owing to rising demand from shale gas operations taking place abundantly in this region. Countries like the US and Canada are boosting regional market value.
*Note:
1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it
